AGREEMENTAmendment No. 2 to Schedule 13g • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 15th, 2022 Company IndustryThe undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, $0.001 par value, of Spectrum Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
AGREEMENT The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 9, 2007 relating to the Common Stock, $.002 par value of Everlast Worldwide Inc. shall be filed on behalf of the undersigned. GUERRILLA CAPITAL MANAGEMENT, LLCAmendment No. 2 to Schedule 13g • February 9th, 2007 • Guerrilla Capital Management LLC • Women's, misses', and juniors outerwear
Contract Type FiledFebruary 9th, 2007 Company IndustryThe undersigned agree that this Amendment No. 2 to Schedule 13G dated February 9, 2007 relating to the Common Stock, $.002 par value of Everlast Worldwide Inc. shall be filed on behalf of the undersigned.
AGREEMENTAmendment No. 2 to Schedule 13g • February 15th, 2022 • Armistice Capital, LLC • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 15th, 2022 Company IndustryThe undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, $0.001 par value, of Voyager Therapeutics, Inc. shall be filed on behalf of the undersigned.
AGREEMENTAmendment No. 2 to Schedule 13g • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 15th, 2022 Company IndustryThe undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, $0.001 par value, of Supernus Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.